Investor’s Business Daily |
Sanofi, Regeneron Dip As Eczema Drug Dupixent Lags In Europe
Investor’s Business Daily Technology. Sanofi, Regeneron Dip As Eczema Drug Dupixent Lags In Europe. ALLISON GATLIN; 2/07/2018. Facebook · LinkedIn · Twitter · Print · Share. Reprints. Sanofi (SNY) and Regeneron Pharmaceuticals' (REGN) Dupixent is off to a strong start in the U … |
